GEVO files Form 144 to sell 200,000 shares
GEVO reported a proposed sale of Common Stock totaling 200,000 shares in a Form 144 notice.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
GEVO reported a proposed sale of Common Stock totaling 200,000 shares in a Form 144 notice. The filing lists an aggregate value of $551,480.00 and references Nasdaq. The excerpt also itemizes restricted stock units granted on 08/20/2022, 07/26/2023, 07/06/2021, and 07/06/2022 with separate share counts.
The notice appears administrative: it lists the securities to be sold and equity compensation awards but does not describe buyer identity, execution method, or timing beyond the Form 144 record.
Insights
Form 144 lists a proposed sale of Common Stock and related equity awards; it is an administrative notice.
The filing excerpt shows a proposed sale of 200,000 shares of Common Stock and an aggregate value line of $551,480.00. Form 144s notify the SEC of intended brokered sales by affiliates; they do not themselves execute transfers.
Execution, timing, and purchaser details are not provided in the excerpt. Subsequent Form 4s or broker records would show completed transactions; current cash‑flow treatment and proceeds recipient are not disclosed here.
Key Figures
Key Terms
Restricted Stock Units financial
Equity Compensation financial
Form 144 regulatory
Nasdaq market
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Are the Restricted Stock Units listed in GEVO's Form 144 being sold?
Will a completed sale appear after Form 144 for GEVO?
AI-generated analysis. How Rhea-AI works. Not financial advice.